yahong cheng

Dr. yahong cheng


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Biochemical Pharmacology
Verified
Journal Article
Closed access
YCyahong cheng
yahong cheng
QMQianting Mai
Qianting Mai
XZXin Zeng
Xin Zeng
HWHuiling Wang
Huiling Wang
YXYao Xiao
Yao Xiao
HDHong Ding
Hong Ding

28 April 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
QWQin Wu
Qin Wu
JDJiajun Dong
Jiajun Dong
XBXinying Bai
Xinying Bai
YJYuan Jiang
Yuan Jiang
JLJinjin Li
Jinjin Li
GJGaofeng Jiang
Gaofeng Jiang

23 January 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
YCyahong cheng
yahong cheng
FLFei Luo
Fei Luo
QZQianying Zhang
Qianying Zhang
YSYing Sang
Ying Sang
XCXiaofang Chen
Xiaofang Chen
YMYun Mei
Yun Mei
Epilepsy (EP) is a type of chronic brain disease characterized by transient central nervous system malfunction which is the result of neuron paradoxical discharge in the brain. In a recent study, we evaluated the neuroprotective effect of α-lipoic acid on pentetrazol-induced rats. Epileptic rats were induced by intraperitoneal injection of pentetrazol (35 mg kg−1), and were intragastrically administered with α-lipoic acid for a month. The treatment with α-lipoic acid significantly reduced the total frequency of epileptic seizures and improved the behavior impairment and cognitive disorder caused by pentetrazol toxicity. With the administration of α-lipoic acid, not only did the apoptosis rate of nerve cells decrease, but also the formation of nitric oxide and malondialdehyde was inhibited. We also recorded evidence suggesting the treatment of α-lipoic acid could enhance the activity of antioxidant enzymes. Furthermore, in the hippocampus area of the brain, α-lipoic acid treatment promoted the translocation of Nrf2 in the nuclear fraction and increased the expression of HO-1 and NQO1. Our data indicated that α-lipoic acid may be a potential candidate for lessening the number of epileptic attacks, improving the behavior and cognitive disorder and cutting down the apoptosis rate of nerve cells in a pentetrazol-induced rat model through activating the Nrf2 signaling pathway.

9 January 2024 in Journal of Neurochemistry
Verified
Journal Article
Closed access
YCyahong cheng
yahong cheng
PHPuxin Huang
Puxin Huang
QZQixian Zou
Qixian Zou
HTHui Tian
Hui Tian
QCQingzhou Cheng
Qingzhou Cheng
HDHong Ding
Hong Ding

6 July 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
XCXiaofang Chen
Xiaofang Chen
JTJianyang Tan
Jianyang Tan
LZLu Zhang
Lu Zhang
YLYonggang Liu
Yonggang Liu
YCyahong cheng
yahong cheng
HDHong Ding
Hong Ding
(A) Chemical structure of apigenin. (B) Graph illuminating the experimental design for the time course of fructose and apigenin administration, and the timelines for the histological studies, biochemical analysis and western blot analysis.

8 December 2025 in Nutritional Neuroscience
Verified
Journal Article
Closed access
HTHui Tian
Hui Tian
YZYu Zhang
Yu Zhang
SXSiyue Xiao
Siyue Xiao
JCJing Cai
Jing Cai
HQHouhao Qi
Houhao Qi
YCyahong cheng
yahong cheng
Objective: Targeting the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway represents a promising therapeutic strategy for multiple sclerosis (MS). However, approved drugs like dimethyl fumarate (DMF) often induce severe side effects. This study investigated the natural flavonoid luteolin (LUT) as a potential dietary supplement alternative to DMF in a cuprizone (CPZ)-induced demyelination mouse model of MS.Methods: Mice were randomly assigned to five groups: control, CPZ model, CPZ+DMF (15 mg/kg), CPZ+LUT (25 mg/kg), and CPZ+LUT (50 mg/kg). Motor coordination and spatial memory were assessed via rotarod and Morris water maze tests. Myelin integrity was evaluated by Luxol fast blue staining and myelin basic protein (MBP) immunofluorescence/Western blot. Oxidative stress was measured by assessing superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) activities and malondialdehyde (MDA) levels. Nrf2 pathway activation was analyzed by nuclear translocation of Nrf2 and expression of downstream proteins (HO-1, NQO1) via Western blot. Molecular docking simulated interactions between compounds and the Keap1 protein.Results: LUT treatment significantly restored motor coordination and spatial memory, with efficacy comparable to DMF. It promoted MBP expression, attenuated oxidative damage by modulating SOD, CAT, GSH-Px, and MDA levels, and preserved myelin integrity. Furthermore, LUT markedly facilitated Nrf2 nuclear translocation and upregulated HO-1 and NQO1 expression. Molecular docking indicated that LUT possessed stronger binding affinity to the target protein Keap1 and a lower potential for off-target toxicity compared to the primary active metabolite of DMF.Conclusion: Luteolin exerts significant neuroprotective effects, primarily via Nrf2 pathway activation, with efficacy parallel to DMF but a superior safety profile. These findings identify LUT as a promising natural compound, bridging functional foods and MS therapy, and provide a foundation for developing LUT-enriched dietary regimens as an adjunct treatment strategy for MS.